A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

NCT01800526 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Anemia

Interventions

DRUG: N-Acetylcysteine

Sponsor

Bloodworks

Collaborators

[object Object]